– AAVs are nonpathogenic DNA viruses recognized for their ability to deliver genes effectively.
– They have become essential tools in advancing gene therapy techniques.
– Despite intensive therapeutic use, numerous fundamental aspects of AAV biology remain poorly understood.
India is an emerging hub for biotechnology research and innovation, with notable investments being poured into fields like gene therapy. Understanding the natural biology of AAVs could become pivotal as domestic biotech firms begin incorporating thes tools into treatments for genetic disorders and other ailments. While this development underlines the global nature of scientific exploration, it also creates opportunities for India to contribute original research that addresses gaps in knowledge about AAV biology.
In addition, as India’s population faces a rising burden of genetic diseases due to its large base size and genetic diversity, advancing work on vectors like AAVs aligns with national healthcare imperatives. Patent policies must ensure local access while balancing incentives for innovation-a critical future test in this evolving field.